STOCK TITAN

Incyte to Report Fourth Quarter and Year-End 2022 Financial Results

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Incyte has announced its fourth quarter and year-end 2022 financial results conference call scheduled for 8:00 a.m. ET on February 7, 2023. Investors can access the press release at 7:00 a.m. ET on the same day. The domestic dial-in number for the call is 877-407-3042 and the international number is 201-389-0864, using conference ID 13735569 for participation. A replay will be available for 30 days, with U.S. replay at 877-660-6853. The live webcast will be accessible at Investor.Incyte.com for 90 days.

Positive
  • None.
Negative
  • None.

WILMINGTON, Del.--(BUSINESS WIRE)-- Incyte (Nasdaq:INCY) announced today that it has scheduled its fourth quarter and year-end 2022 financial results conference call and webcast for 8:00 a.m. ET on Tuesday, February 7, 2023.

The schedule for the press release and conference call/webcast is as follows:

  • Q4 & YE 2022 Press Release: February 7, 2023 at 7:00 a.m. ET
  • Q4 & YE 2022 Conference Call: February 7, 2023 at 8:00 a.m. ET
  • Domestic Dial-In Number: 877-407-3042
  • International Dial-In Number: 201-389-0864
  • Conference ID Number: 13735569

If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and the dial-in number for international callers is 201-612-7415. To access the replay you will need the conference ID number 13735569.

The live webcast with slides can be accessed at Investor.Incyte.com and will be available for replay for 90 days.

About Incyte 
Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit Incyte.com and follow @Incyte.

Incyte Contacts

Media

Catalina Loveman

+1 302 498 6171

cloveman@incyte.com

Investors

Christine Chiou

+1 302 274 4773

cchiou@incyte.com

Source: Incyte

FAQ

When will Incyte release its Q4 and year-end 2022 financial results?

Incyte will release its Q4 and year-end 2022 financial results on February 7, 2023, at 7:00 a.m. ET.

What time is the Incyte Q4 financial results conference call?

The Incyte Q4 financial results conference call is scheduled for 8:00 a.m. ET on February 7, 2023.

How can I access the Incyte conference call?

You can access the Incyte conference call by dialing 877-407-3042 for domestic calls and 201-389-0864 for international calls, using conference ID 13735569.

Will a replay of the Incyte conference call be available?

Yes, a replay of the Incyte conference call will be available for 30 days after the call.

Where can I watch the Incyte financial results webcast?

The Incyte financial results webcast can be viewed at Investor.Incyte.com.

Incyte Genomics Inc

NASDAQ:INCY

INCY Rankings

INCY Latest News

INCY Stock Data

13.56B
188.30M
2.04%
97.86%
3.85%
Biotechnology
Services-commercial Physical & Biological Research
Link
United States of America
WILMINGTON